All Articles
This is the first time the FDA has used minimal residual disease (MRD) as a biomarker to approve a specific treatment for patients with acute lymphoblastic leukemia (ALL). Read More ›
A national advocacy program trains patients with metastatic breast cancer to educate the public about the special needs of patients with advanced breast cancer. Read More ›
Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer. Read More ›
By Laura Morgan
The terms genetics and genomics are often used interchangeably in relation to cancer, but they refer to different things and are becoming very important in cancer treatment. Read More ›
By Dana Taylor
Read about important advancements in tumor biomarkers and their role in guiding treatment in some types of cancer. Read More ›
By Kelsey Moroz
CancerSEEK is a noninvasive blood test that may help detect cancer in early stages, when treatment has the highest chance for success. Read More ›
Liquid biopsy is a noninvasive blood test that can help identify cancerous cells or biomarkers, such as gene mutations that may respond to targeted therapies. Read More ›
Targeted therapies for lung cancer are newer therapies designed to target specific types of genetic mutations found in some patients, and improve the response to treatment. Read More ›